POTOMAC, MD / ACCESS Newswire / September 9, 2025 / IGC Pharma, Inc. (NYSE American:IGC), a clinical-stage pharmaceutical company focused on therapies for Alzheimer's disease, today announced that its ...
"Receiving recognition for clean code development reflects our deep commitment to scientific rigor, transparency, and collaboration," said Ram Mukunda, CEO of IGC Pharma. "By making our AI work both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results